Standardizing steroid protocols for newly diagnosed inflammatory bowel disease patients: A quality improvement initiative

被引:0
作者
Lendner, Nuphar [1 ]
Perry, Sharon [2 ]
Sferra, Thomas J. [2 ]
Moses, Jonathan [3 ]
Young, Denise D. [2 ,4 ]
机构
[1] Pediatrix Gastroenterol Rocky Mt, Denver, CO USA
[2] UH Rainbow Babies & Childrens Hosp, Div Pediat Gastroenterol Hepatol & Nutr, Cleveland, OH USA
[3] Stanford Univ, Sch Med, Div Pediat Gastroenterol, Palo Alto, CA USA
[4] 11100 Euclid Ave,Mailstop RBC 6004, Cleveland, OH 44106 USA
关键词
adalimumab; corticosteroids; Crohn disease; infliximab; ulcerative colitis; CROHNS-DISEASE; MEDICAL RECORD; VALIDATION; MANAGEMENT; TRENDS;
D O I
10.1002/jpn3.12246
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
ObjectivesSystemic steroids can be used for induction of inflammatory bowel disease (IBD), but are not recommended as long-term therapy. Steroid weaning requires rigorous monitoring of symptoms, which may be cumbersome and lead to missed opportunities. We aim to describe our local quality improvement (QI) initiative to improve and standardize the steroid weaning process.MethodsAfter identifying drivers of steroid weaning, a protocol was developed and implemented for newly diagnosed IBD patients started on steroids and subsequently initiated on anti-TNF-alpha therapy. Interventions included development of a tapering schedule, and standardizing communication with patients and evaluation of symptoms. The primary aim was to increase the percent of patients called on a weekly basis by 20%; secondary aims were to decrease the median steroid days by 25% and to increase the number of our patients weaned off steroids at 8 weeks from 35% to 75% by 1 year after the initiative.ResultsThe median percent of patients called on a weekly basis to assess clinical symptoms and to wean steroids increased to 80% after 1 year. The median number of systemic corticosteroid days decreased from 67.5 to 50.5 days post-protocol implementation with 61.1% patients weaned off by 8 weeks from discharge. Zero patients were admitted for flares with the protocol implementation.ConclusionOur experience illustrates that QI methodology can be used successfully to improve and standardize the steroid weaning process, leading to shortened steroid duration and without increased flares and hospitalizations. What is Known Systemic steroids can be used to induce remission in pediatric IBD patients but should not be used for long term therapy due to abundance of adverse effects. Steroids should be weaned with initiation of long term therapy for pediatric patients with IBD.What is New Standardization of steroid titration protocols through QI methodology prevented missed opportunities for weaning and unnecessary prolongation of steroid duration. Utilization of electronic medical record improves steroid tapering in pediatric IBD.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 18 条
  • [1] [Anonymous], 2018, AM J GASTROENTEROL, V113, P1101
  • [2] Utilization of an Electronic Medical Record-integrated Dashboard Improves Identification and Treatment of Anemia and Iron Deficiency in Pediatric Inflammatory Bowel Disease
    Breton, Jessica
    Witmer, Char M.
    Zhang, Yuchen
    Downing, Maura
    Stevenson, Jamie
    McDermott, Janine
    Siddique, Shazia M.
    Grossman, Andrew B.
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 (09) : 1409 - 1417
  • [3] Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice
    Bruscoli, Stefano
    Febo, Marta
    Riccardi, Carlo
    Migliorati, Graziella
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [4] Steroid dependency and trends in prescribing for inflammatory bowel disease - a 20-year national population-based study
    Chhaya, V.
    Saxena, S.
    Cecil, E.
    Subramanian, V.
    Curcin, V.
    Majeed, A.
    Pollok, R. C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (05) : 482 - 494
  • [5] Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn's Disease: A Systematic Review and Pooled Meta-analysis
    Faleck, David M.
    Shmidt, Eugenia
    Huang, Ruiqi
    Katta, Leah G.
    Narula, Neeraj
    Pinotti, Rachel
    Suarez-Farinas, Mayte
    Colombel, Jean-Frederic
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (02) : 238 - +
  • [6] Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
    Ford, Alexander C.
    Bernstein, Charles N.
    Khan, Khurram J.
    Abreu, Maria T.
    Marshall, John K.
    Talley, Nicholas J.
    Moayyedi, Paul
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04) : 590 - 599
  • [7] DEVELOPMENT AND VALIDATION OF A PEDIATRIC CROHNS-DISEASE ACTIVITY INDEX
    HYAMS, JS
    FERRY, GD
    MANDEL, FS
    GRYBOSKI, JD
    KIBORT, PM
    KIRSCHNER, BS
    GRIFFITHS, AM
    KATZ, AJ
    GRAND, RJ
    BOYLE, JT
    MICHENER, WM
    LEVY, JS
    LESSER, ML
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1991, 12 (04) : 439 - 447
  • [8] Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort
    Jeuring, Steven F. G.
    Biemans, Vince B. C.
    van den Heuvel, Tim R. A.
    Zeegers, Maurice P.
    Hameeteman, Wim H.
    Romberg-Camps, Marielle J. L.
    Oostenbrug, Liekele E.
    Masclee, Ad A. M.
    Jonkers, Daisy M. A. E.
    Pierik, Marieke J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (03) : 384 - 395
  • [9] Reduced Systemic Corticosteroid Use among Pediatric Patients With Inflammatory Bowel Disease in a Large Learning Health System
    Kandavel, Prashanthi
    Eder, Sally J.
    Adler, Jeremy
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 73 (03) : 345 - 351
  • [10] ACG Clinical Guideline: Management of Crohn's Disease in Adults
    Lichtenstein, Gary R.
    Loft, Edward V., Jr.
    Isaacs, Kim L.
    Regueiro, Miguel D.
    Gerson, Lauren B.
    Sands, Bruce E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (04) : 481 - 517